The TMPRSS2-ERG fusion is one of the most common genetic alterations in PCa, leading to the androgen-regulated overexpression of ERG oncogene, which affects the expression of numerous signaling pathways and genes including Neuropeptide Y (NPY) (25–27). The gene discussed is TMPRSS2; the disease is posterior cortical atrophy.